We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$30.4B
AUM Growth
+$2.48B
Cap. Flow
-$858M
Cap. Flow %
-2.83%
Top 10 Hldgs %
26.66%
Holding
1,016
New
57
Increased
377
Reduced
410
Closed
56

Top Buys

Rank Stock Value
1
FLUT icon
Flutter Entertainment
FLUT
+$154M
2
NVDA icon
NVIDIA
NVDA
+$32.5M
3
IR icon
Ingersoll Rand
IR
+$28.9M
4
CL icon
Colgate-Palmolive
CL
+$27.7M
5
WSM icon
Williams-Sonoma
WSM
+$27.6M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$83.9M
2
CRH icon
CRH
CRH
+$55.9M
3
LHX icon
L3Harris
LHX
+$37.2M
4
RCL icon
Royal Caribbean
RCL
+$35.7M
5
SPLK
Splunk Inc
SPLK
+$29.9M

Sector Composition

Rank Sector Weight
1 Technology 27.5%
2 Financials 14.06%
3 Healthcare 12.17%
4 Consumer Discretionary 10.3%
5 Industrials 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXP icon
676
Eagle Materials
EXP
$6.49B
$668K ﹤0.01%
2,457
-1,797
-42% -$425K
SXI icon
677
Standex International
SXI
$3.33B
$667K ﹤0.01%
3,662
-712
-16% -$115K
CORT icon
678
Corcept Therapeutics
CORT
$9.98B
$667K ﹤0.01%
26,485
+4,072
+18% +$96.2K
AYI icon
679
Acuity Brands
AYI
$9.99B
$665K ﹤0.01%
2,475
-5,059
-67% -$1.23M
AOS icon
680
A.O. Smith
AOS
$8.55B
$665K ﹤0.01%
7,434
-505
-6% -$41.6K
HRMY icon
681
Harmony Biosciences
HRMY
$2.08B
$664K ﹤0.01%
19,771
-475
-2% -$15.2K
APAM icon
682
Artisan Partners
APAM
$2.86B
$663K ﹤0.01%
14,475
-996
-6% -$42.8K
AIT icon
683
Applied Industrial Technologies
AIT
$12.4B
$662K ﹤0.01%
3,352
-307
-8% -$56.1K
HCC icon
684
Warrior Met Coal
HCC
$4.17B
$662K ﹤0.01%
10,901
-85
-0.8% -$5.15K
FELE icon
685
Franklin Electric
FELE
$4.66B
$662K ﹤0.01%
6,194
-520
-8% -$51.3K
TYL icon
686
Tyler Technologies
TYL
$13.7B
$660K ﹤0.01%
1,554
-4,617
-75% -$1.97M
YELP icon
687
Yelp
YELP
$1.54B
$659K ﹤0.01%
16,725
+3,266
+24% +$135K
EXPO icon
688
Exponent
EXPO
$3.19B
$659K ﹤0.01%
7,964
+401
+5% +$33.2K
ERII icon
689
Energy Recovery
ERII
$420M
$658K ﹤0.01%
+41,674
New +$663K
ROCK icon
690
Gibraltar Industries
ROCK
$1.28B
$658K ﹤0.01%
8,168
-351
-4% -$28K
CNS icon
691
Cohen & Steers
CNS
$4.2B
$657K ﹤0.01%
8,545
-1,186
-12% -$84.7K
LQDT icon
692
Liquidity Services
LQDT
$1.2B
$656K ﹤0.01%
+35,295
New +$613K
CPRX
693
DELISTED
Catalyst Pharmaceutical
CPRX
$656K ﹤0.01%
41,157
-1,977
-5% -$29.8K
MLI icon
694
Mueller Industries
MLI
$14.5B
$655K ﹤0.01%
24,308
-4,114
-14% -$102K
LMAT icon
695
LeMaitre Vascular
LMAT
$2.37B
$655K ﹤0.01%
9,875
-1,411
-13% -$87.1K
VYGR icon
696
Voyager Therapeutics
VYGR
$181M
$654K ﹤0.01%
70,285
-12,498
-15% -$106K
JBSS icon
697
John B. Sanfilippo & Son
JBSS
$986M
$654K ﹤0.01%
6,172
-189
-3% -$19.5K
AGX icon
698
Argan
AGX
$6.9B
$653K ﹤0.01%
12,927
-430
-3% -$20.2K
BKE icon
699
Buckle
BKE
$2.32B
$653K ﹤0.01%
16,217
+1,125
+7% +$44.2K
CRC icon
700
California Resources
CRC
$4.49B
$653K ﹤0.01%
11,843
+3,971
+50% +$207K

Similar funds

Aviva's Q1 2024 Portfolio in Review

As of Q1 2024, Aviva held 1,016 positions worth $30.4B, up 8.9% from $27.9B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Aviva's Q1 2024 filing shows 57 new, 377 increased, 410 reduced and 56 closed positions. Its largest new stake was Flutter Entertainment: 719,487 shares worth $144M. The largest sale was Apple, an estimated $83.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • Aviva's largest Q1 2024 buy was Flutter Entertainment: 719,487 shares worth $144M.
  • Aviva added most to NVIDIA in Q1 2024, an estimated $32.5M increase.
  • Aviva's biggest Q1 2024 reduction was Apple, cutting an estimated $83.9M.
  • Aviva fully exited Splunk Inc in Q1 2024, selling an estimated $29.9M.
  • Aviva's ten largest holdings make up 27% of its $30.4B portfolio in Q1 2024.
  • Aviva opened 57 new positions and closed 56 in Q1 2024.
  • Aviva's portfolio value rose 8.9% quarter-over-quarter to $30.4B.

Based on Aviva's 13F filing for Q1 2024, filed 14 May 2024.